[Federal Register Volume 76, Number 108 (Monday, June 6, 2011)] [Notices] [Page 32367] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2011-13871] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-1999-D-0742 (formerly Docket No. 1999D-4396)] Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of May 24, 2011 (76 FR 30175). The document announced the availability of a draft guidance entitled `` Draft Guidance for Clinical Investigators, Industry, and FDA Staff: Financial Disclosure by Clinical Investigators.''The document was published with an incorrect docket number. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208, Silver Spring, MD 20993-0002, 301-796-9148. SUPPLEMENTARY INFORMATION: In FR Doc. 2011-12623, appearing on page 30175, in the Federal Register of Tuesday, May 24, 2011, the following correction is made: 1. On page 30175, in the second column, in the Docket No. heading, ``[Docket No. FDA-1999-D-0792] (Formerly FDA-1999-D-0792)'' is corrected to read ``[Docket No. FDA-1999-D-0742] (formerly Docket No. 1999D-4396)''. Dated: May 31, 2011. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2011-13871 Filed 6-3-11; 8:45 am] BILLING CODE 4160-01-P